Skip to main content
Veterinary Medicines

Halofusol 0.5 mg/ml oral solution for calves

Authorised
  • Halofuginone lactate

Auðkenning lyfsins

Heiti lyfs:
Halofusol 0.5 mg/ml oral solution for calves
Halofusol 0.5 mg/ml oral solution for calves
Virkt efni:
Dýrategundir:
  • Nautgripir (nýfæddur kálfur)
Íkomuleið:
  • Til inntöku

Upplýsingar um lyfið

Virkt efni / Styrkur:
  • Aðeins í boði í English
    0.61
    milligram(s)
    /
    1.00
    millilitre(s)
Lyfjaform:
  • Mixtúra, lausn
Withdrawal period by route of administration:
  • Oral use
    • Nautgripir (nýfæddur kálfur)
      • Kjöt og innmatur
        13
        dagar
ATC flokkun (dýralyf):
  • QP51BX01
Staða markaðsleyfis:
  • Gilt
Authorised in:
  • Írland
Áletrun:

Viðbótarupplýsingar

Entitlement type:
  • Markaðsleyfi
Markaðsleyfishafi:
  • Laboratorios Karizoo S.A.
Marketing authorisation date:
Framleiðandi sem ber ábyrgð á lokasamþykkt:
  • Laboratorios Karizoo S.A.
Ábyrgt yfirvald:
  • Health Products Regulatory Authority
Markaðsleyfisnúmer:
  • VPA10786/007/001
Dagsetning leyfisbreytingar:
Umsjónarland (RMS):
  • Spánn
Númer verkferlis:
  • ES/V/0351/001
Þátttökulönd (CMS):
  • Belgía
  • Kýpur
  • Danmörk
  • Eistland
  • Frakkland
  • Þýskaland
  • Grikkland
  • Ungverjaland
  • Írland
  • Ítalía
  • Lettland
  • Litáen
  • Holland
  • Pólland
  • Portúgal
  • Rúmenía
  • Bretland (Norður-Írland)
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."